Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
04-17 | BTIG Adjusts Price Target on Cullinan Oncology to $30 From $20, Maintains Buy Rating | MT |
04-16 | HC Wainwright Cuts Cullinan Oncology's Price Target to $29 From $34, Maintains Buy Rating | MT |
Sales 2015 | - | Sales 2016 | - | Capitalization | 5.08M 6.94M |
---|---|---|---|---|---|
Net income 2015 | - 0 | Net income 2016 | - 0 | EV / Sales 2015 | - |
Net Debt 2015 | 1.09M 1.48M | Net Debt 2016 | 330K 451K | EV / Sales 2016 | - |
P/E ratio 2015 |
-96.2
x | P/E ratio 2016 |
-17.6
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 17.15% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 47 | - | |
Peter James Lee
DFI | Director of Finance/CFO | 66 | 08-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 47 | - |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4M | |
-5.74% | 4.11B | |
+2.65% | 1.55B | |
+33.83% | 1.25B | |
+32.63% | 917M | |
+82.85% | 881M | |
-24.60% | 561M | |
+12.36% | 558M | |
-.--% | 153M | |
+5.45% | 106M |
- Stock Market
- Equities
- CGEM Stock